Role of glycosylation in TGF-β signaling and epithelial-to-mesenchymal transition in cancer

Abstract

Glycosylation is a common posttranslational modification on membrane-associated and secreted proteins that is of pivotal importance for regulating cell functions. Aberrant glycosylation can lead to uncontrolled cell proliferation, cell-matrix interactions, migration and differentiation, and has been shown to be involved in cancer and other diseases. The epithelial-to-mesenchymal transition is a key step in the metastatic process by which cancer cells gain the ability to invade tissues and extravasate into the bloodstream. This cellular transformation process, which is associated by morphological change, loss of epithelial traits and gain of mesenchymal markers, is triggered by the secreted cytokine transforming growth factor-β (TGF-β). TGF-β bioactivity is carefully regulated, and its effects on cells are mediated by its receptors on the cell surface. In this review, we first provide a brief overview of major types of glycans, namely, N-glycans, O-glycans, glycosphingolipids and glycosaminoglycans that are involved in cancer progression. Thereafter, we summarize studies on how the glycosylation of TGF-β signaling components regulates TGF-β secretion, bioavailability and TGF-β receptor function. Then, we review glycosylation changes associated with TGF-β-induced epithelial-tomesenchymal transition in cancer. Identifying and understanding the mechanisms by which glycosylation affects TGF-β signaling and downstream biological responses will facilitate the identification of glycans as biomarkers and enable novel therapeutic approaches.

Keywords

cancer / epithelial-to-mesenchymal transition / glycosphingolipids / N-glycosylation / O-glycosylation / transforming growth factor-β

References

[1] Albertsen PC (2018) Prostate cancer screening with prostatespecific antigen: where are we going? Cancer 124:453–455

[2] Alteen MG, Gros C, Meek RW, Cardoso DA, Busmann JA, Sangouard G, Deen MC, Tan HY, Shen DL, Russell CC (2020) A direct fluorescent activity assay for glycosyltransferases enables convenient high-throughput screening: application to O-GlcNAc transferase. Angew Chem Int Ed Engl 59:1–11

[3] Andergassen U, Liesche F, Kolbl AC, Ilmer M, Hutter S, Friese K, Jeschke U (2015) Glycosyltransferases as markers for early tumorigenesis. Biomed Res Int 2015(792672):1–11

[4] Andres JL, DeFalcis D, Noda M, Massague J (1992) Binding of two growth factor families to separate domains of the proteoglycan betaglycan. J Biol Chem 267:5927–5930

[5] Auclin E, Andre T, Taieb J, Benetkiewicz M, de Gramont A, Vernerey D (2018) Low-level postoperative carcinoembryonic antigen improves survival outcomes stratification in patients with stage II colon cancer treated with standard adjuvant treatments. Eur J Cancer 97:55–56

[6] Ballehaninna UK, Chamberlain RS (2012) The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: an evidence based appraisal. J Gastrointest Oncol 3:105–119

[7] Bassaganas S, Carvalho S, Dias AM, Perez-Garay M, Ortiz MR, Figueras J, Reis CA, Pinho SS, Peracaula R (2014) Pancreatic cancer cell glycosylation regulates cell adhesion and invasion through the modulation of α2β1 integrin and E-cadherin function. PLoS ONE 9(e98595):1–14

[8] Batlle E, Massague J (2019) Transforming growth factor-β signaling in immunity and cancer. Immunity 50:924–940

[9] Boscher C, Dennis JW, Nabi IR (2011) Glycosylation, galectins and cellular signaling. Curr Opin Cell Biol 23:383–392

[10] Breimer ME, Saljo K, Barone A, Teneberg S (2017) Glycosphingolipids of human embryonic stem cells. Glycoconj J 34:713–723

[11] Brockhausen I, Stanley P (2015) O-GalNAc glycans. In: Varki A, Cummings RD, Esko JD, Stanley P, Hart GW, Aebi M, Darvill AG, Kinoshita T, Packer NH et al (eds) Essentials of glycobiology, 3rd edn. Cold Spring Harbor, New York, pp 113–123

[12] Brunner AM, Lioubin MN, Marquardt H, Malacko AR, Wang WC, Shapiro RA, Neubauer M, Cook J, Madisen L, Purchio AF (1992) Site-directed mutagenesis of glycosylation sites in the transforming growth factor-beta 1 (TGFβ1) and TGFβ2 (414) precursors and of cysteine residues within mature TGFβ1: effects on secretion and bioactivity. Mol Endocrinol 6:1691–1700

[13] Budi EH, Duan D, Derynck R (2017) Transforming growth factor-β receptors and smads: regulatory complexity and functional versatility. Trends Cell Biol 27:658–672

[14] Chaudhary PM, Toraskar S, Yadav R, Hande A, Yellin RA, Kikkeri R (2019) Multivalent sialosides: a tool to explore the role of sialic acids in biological processes. Chem Asian J 14:1344–1355

[15] Chen X, Varki A (2010) Advances in the biology and chemistry of sialic acids. ACS Chem Biol 5:163–176

[16] Cheng J, Wang W, Zhang Y, Liu X, Li M, Wu Z, Liu Z, Lv Y, Wang B (2014) Prognostic role of pre-treatment serum AFP-L3% in hepatocellular carcinoma: systematic review and meta-analysis. PLoS ONE 9(e87011):1–8

[17] Colak S, Ten Dijke P (2017) Targeting TGF-β signaling in cancer. Trends Cancer 3:56–71

[18] Couto N, Davlyatova L, Evans CA, Wright PC (2018) Application of the broadband collision-induced dissociation (bbCID) mass spectrometry approach for protein glycosylation and phosphorylation analysis. Rapid Commun Mass Spectrom 32:75–85

[19] D’Angelo G, Capasso S, Sticco L, Russo D (2013) Glycosphingolipids: synthesis and functions. FEBS J 280:6338–6353

[20] Dennis JW, Nabi IR, Demetriou M (2009) Metabolism, cell surface organization, and disease. Cell 139:1229–1241

[21] Derynck R, Muthusamy BP, Saeteurn KY (2014) Signaling pathway cooperation in TGF-β-induced epithelial-mesenchymal transition. Curr Opin Cell Biol 31:56–66

[22] Derynck R, Weinberg RA (2019) EMT and cancer: more than meets the eye. Dev Cell 49:313–316

[23] Ding Y, Gelfenbeyn K, Freire-de-Lima L, Handa K, Hakomori SI (2012) Induction of epithelial-mesenchymal transition with O-glycosylated oncofetal fibronectin. FEBS Lett 586:1813–1820

[24] Dochez V, Caillon H, Vaucel E, Dimet J, Winer N, Ducarme G (2019) Biomarkers and algorithms for diagnosis of ovarian cancer: CA125, HE4, RMI and ROMA, a review. J Ovarian Res 12(28):1–9

[25] Dong X, Hudson NE, Lu C, Springer TA (2014) Structural determinants of integrin β-subunit specificity for latent TGF-β. Nat Struct Mol Biol 21:1091–1096

[26] Du J, Hong S, Dong L, Cheng B, Lin L, Zhao B, Chen YG, Chen X (2015) Dynamic sialylation in transforming growth factor-beta (TGF-β)-induced epithelial to mesenchymal transition. J Biol Chem 290:12000–12013

[27] Dube DH, Bertozzi CR (2005) Glycans in cancer and inflammation–potential for therapeutics and diagnostics. Nat Rev Drug Discov 4:477–488

[28] Esparza-Lopez J, Montiel JL, Vilchis-Landeros MM, Okadome T, Miyazono K, Lopez-Casillas F (2001) Ligand binding and functional properties of betaglycan, a co-receptor of the transforming growth factor-β superfamily. Specialized binding regions for transforming growth factor-β and inhibin A. J Biol Chem 276:14588–14596

[29] Ferreira IG, Pucci M, Venturi G, Malagolini N, Chiricolo M, Dall’Olio F (2018) Glycosylation as a main regulator of growth and death factor receptors signaling. Int J Mol Sci 19:1–28

[30] Freire-de-Lima L (2014) Sweet and sour: the impact of differential glycosylation in cancer cells undergoing epithelial-mesenchymal transition. Front Oncol 4(59):1–10

[31] Freire-de-Lima L, Gelfenbeyn K, Ding Y, Mandel U, Clausen H, Handa K, Hakomori SI (2011) Involvement of O-glycosylation defining oncofetal fibronectin in epithelial-mesenchymal transition process. Proc Natl Acad Sci USA 108:17690–17695

[32] Furukawa K, Ohmi Y, Ohkawa Y, Bhuiyan RH, Zhang P, Tajima O, Hashimoto N, Hamamura K, Furukawa K (2019) New era of research on cancer-associated glycosphingolipids. Cancer Sci 110:1544–1551

[33] Fuster MM, Esko JD (2005) The sweet and sour of cancer: glycans as novel therapeutic targets. Nat Rev Cancer 5:526–542

[34] Gargano AFG, Schouten O, van Schaick G, Roca LS, van den Berg-Verleg JH, Haselberg R, Akeroyd M, Abello N, Somsen GW (2020) Profiling of a high mannose-type N-glycosylated lipase using hydrophilic interaction chromatography-mass spectrometry. Anal Chim Acta 1109:69–77

[35] Glinka Y, Prud’homme GJ (2008) Neuropilin-1 is a receptor for transforming growth factor β1, activates its latent form, and promotes regulatory T cell activity. J Leukoc Biol 84:302–310

[36] Glinka Y, Stoilova S, Mohammed N, Prud’homme GJ (2011) Neuropilin-1 exerts co-receptor function for TGF-β1 on the membrane of cancer cells and enhances responses to both latent and active TGF-β. Carcinogenesis 32:613–621

[37] Gomes C, Osorio H, Pinto MT, Campos D, Oliveira MJ, Reis CA (2013) Expression of ST3GAL4 leads to SLe(x) expression and induces c-Met activation and an invasive phenotype in gastric carcinoma cells. PLoS One 8(e66737):1–13

[38] Gotoh T, Iwahana H, Kannan S, Marei RG, Mousa H, Elgamal M, Souchelnytskyi S (2020) Glycosylation is a novel TGFβ1-independent post-translational modification of Smad2. Biochem Biophys Res Commun 521:1010–1016

[39] Gu Y, Mi W, Ge Y, Liu H, Fan Q, Han C, Yang J, Han F, Lu X, Yu W (2010) GlcNAcylation plays an essential role in breast cancer metastasis. Cancer Res 70:6344–6351

[40] Guan F, Handa K, Hakomori SI (2009) Specific glycosphingolipids mediate epithelial-to-mesenchymal transition of human and mouse epithelial cell lines. Proc Natl Acad Sci USA 106:7461–7466

[41] Guo HF, Vander Kooi CW (2015) Neuropilin functions as an essential cell surface receptor. J Biol Chem 290:29120–29126

[42] Haltiwanger RS, Wells L, Freeze HH, Stanley P (2015) Other classes of eukaryotic glycans. In: Varki A, Cummings RD, Esko JD, Stanley P, Hart GW, Aebi M, Darvill AG, Kinoshita T, Packer NH et al (eds) Essentials of glycobiology, 3rd edn. Springer, New York, pp 151–160

[43] Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100:57–70

[44] Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646–674

[45] Hao Y, Baker D, Ten Dijke P (2019) TGF-β-mediated epithelialmesenchymal transition and cancer metastasis. Int J Mol Sci 20:1–34

[46] Heldin CH (2004) Development and possible clinical use of antagonists for PDGF and TGF-β. Ups J Med Sci 109:165–178

[47] Heldin CH, Miyazono K, ten Dijke P (1997) TGF-β signalling from cell membrane to nucleus through SMAD proteins. Nature 390:465–471

[48] Heldin CH, Moustakas A (2016) Signaling receptors for TGF-β family members. Cold Spring Harb Perspect Biol 8:1–33

[49] Hill CS (2016) Transcriptional control by the SMADs. Cold Spring Harb Perspect Biol 8:1–17

[50] Hirakawa M, Takimoto R, Tamura F, Yoshida M, Ono M, Murase K, Sato Y, Osuga T, Sato T, Iyama S (2014) Fucosylated TGF-β receptors transduces a signal for epithelial-mesenchymal transition in colorectal cancer cells. Br J Cancer 110:156–163

[51] Huanna T, Tao Z, Xiangfei W, Longfei A, Yuanyuan X, Jianhua W, Cuifang Z, Manjing J, Wenjing C, Shaochuan Q (2015) GALNT14 mediates tumor invasion and migration in breast cancer cell MCF-7. Mol Carcinog 54:1159–1171

[52] Hubmacher D, Reinhardt DP (2009) One more piece in the fibrillin puzzle. Structure 17:635–636

[53] Hyytiainen M, Penttinen C, Keski-Oja J (2004) Latent TGF-β binding proteins: extracellular matrix association and roles in TGF-β activation. Crit Rev Clin Lab Sci 41:233–264

[54] Iozzo RV, Schaefer L (2015) Proteoglycan form and function: a comprehensive nomenclature of proteoglycans. Matrix Biol 42:11–55

[55] Jenkins LM, Horst B, Lancaster CL, Mythreye K (2018) Dually modified transmembrane proteoglycans in development and disease. Cytokine Growth Factor Rev 39:124–136

[56] Kamada Y, Mori K, Matsumoto H, Kiso S, Yoshida Y, Shinzaki S, Hiramatsu N, Ishii M, Moriwaki K, Kawada N (2012) N-Acetylglucosaminyltransferase V regulates TGF-β response in hepatic stellate cells and the progression of steatohepatitis. Glycobiology 22:778–787

[57] Katsuno Y, Lamouille S, Derynck R (2013) TGF-β signaling and epithelial-mesenchymal transition in cancer progression. Curr Opin Oncol 25:76–84

[58] Kim SJ, Chung TW, Choi HJ, Kwak CH, Song KH, Suh SJ, Kwon KM, Chang YC, Park YG, Chang HW (2013) Ganglioside GM3 participates in the TGF-β1-induced epithelial-mesenchymal transition of human lens epithelial cells. Biochem J 449:241–251

[59] Kim YW, Park J, Lee HJ, Lee SY, Kim SJ (2012) TGF-β sensitivity is determined by N-linked glycosylation of the type II TGF-β receptor. Biochem J 445:403–411

[60] Kirkbride KC, Ray BN, Blobe GC (2005) Cell-surface co-receptors: emerging roles in signaling and human disease. Trends Biochem Sci 30:611–621

[61] Krasnova L, Wong CH (2016) Understanding the chemistry and biology of glycosylation with glycan synthesis. Annu Rev Biochem 85:599–630

[62] Lamouille S, Connolly E, Smyth JW, Akhurst RJ, Derynck R (2012) TGF-β-induced activation of mTOR complex 2 drives epithelialmesenchymal transition and cell invasion. J Cell Sci 125:1259–1273

[63] Lange T, Samatov TR, Tonevitsky AG, Schumacher U (2014) Importance of altered glycoprotein-bound N- and O-glycans for epithelial-to-mesenchymal transition and adhesion of cancer cells. Carbohydr Res 389:39–45

[64] Lau KS, Partridge EA, Grigorian A, Silvescu CI, Reinhold VN, Demetriou M, Dennis JW (2007) Complex N-glycan number and degree of branching cooperate to regulate cell proliferation and differentiation. Cell 129:123–134

[65] Laughlin ST, Bertozzi CR (2009) Imaging the glycome. Proc Natl Acad Sci USA 106:12–17

[66] Lebrin F, Goumans MJ, Jonker L, Carvalho RL, Valdimarsdottir G, Thorikay M, Mummery C, Arthur HM, ten Dijke P (2004) Endoglin promotes endothelial cell proliferation and TGF-β/ALK1 signal transduction. EMBO J 23:4018–4028

[67] Lee J, Ballikaya S, Schonig K, Ball CR, Glimm H, Kopitz J, Gebert J (2013) Transforming growth factor β receptor 2 (TGFBR2) changes sialylation in the microsatellite unstable (MSI) Colorectal cancer cell line HCT116. PLoS ONE 8(e57074):1–10

[68] Lee J, Warnken U, Schnolzer M, Gebert J, Kopitz J (2015) A new method for detection of tumor driver-dependent changes of protein sialylation in a colon cancer cell line reveals nectin-3 as TGFBR2 target. Protein Sci 24:1686–1694

[69] Leerapun A, Suravarapu SV, Bida JP, Clark RJ, Sanders EL, Mettler TA, Stadheim LM, Aderca I, Moser CD, Nagorney DM (2007) The utility of Lens culinaris agglutinin-reactive alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: evaluation in a United States referral population. Clin Gastroenterol Hepatol 5:394–402

[70] Li F, Lin B, Hao Y, Li Y, Liu J, Cong J, Zhu L, Liu Q, Zhang S (2010) Lewis Y promotes growth and adhesion of ovarian carcinomaderived RMG-I cells by upregulating growth factors. Int J Mol Sci 11:3748–3759

[71] Li FF, Liu JJ, Liu DW, Lin B, Hao YY, Cong JP, Zhu LC, Gao S, Zhang SL, Iwamori M (2012) Lewis Y regulates signaling molecules of the transforming growth factor β pathway in ovarian carcinoma-derived RMG-I cells. Int J Oncol 40:1196–1202

[72] Li X, Wang X, Tan Z, Chen S, Guan F (2016) Role of glycans in cancer cells undergoing epithelial-mesenchymal transition. Front Oncol 6(33):1–5

[73] Lin H, Wang D, Wu T, Dong C, Shen N, Sun Y, Sun Y, Xie H, Wang N, Shan L (2011) Blocking core fucosylation of TGF-β1 receptors downregulates their functions and attenuates the epithelialmesenchymal transition of renal tubular cells. Am J Physiol Renal Physiol 300:F1017–1025

[74] Lin WR, Hsu CW, Chen YC, Chang ML, Liang KH, Huang YH, Yeh CT (2014) GALNT14 genotype, alpha-fetoprotein and therapeutic side effects predict post-chemotherapy survival in patients with advanced hepatocellular carcinoma. Mol Clin Oncol 2:630–640

[75] Lindahl U, Couchman J, Kimata K, Esko JD (2015) Proteoglycans and sulfated glycosaminoglycans. In: Varki A, Cummings RD, Esko JD, Stanley P, Hart GW, Aebi M, Darvill AG, Kinoshita T, Packer NH et al (eds) Essentials of glycobiology, 3rd edn. Cold Spring Harbor, New York, pp 207–221

[76] Liu CH, Hu RH, Huang MJ, Lai IR, Chen CH, Lai HS, Wu YM, Huang MC (2014a) C1GALT1 promotes invasive phenotypes of hepatocellular carcinoma cells by modulating integrin β1 glycosylation and activity. PLoS ONE 9(e94995):1–9

[77] Liu T, Zhang S, Chen J, Jiang K, Zhang Q, Guo K, Liu Y (2014b) The transcriptional profiling of glycogenes associated with hepatocellular carcinoma metastasis. PLoS ONE 9(e107941):1–13

[78] Lopez-Casillas F, Cheifetz S, Doody J, Andres JL, Lane WS, Massague J (1991) Structure and expression of the membrane proteoglycan betaglycan, a component of the TGF-β receptor system. Cell 67:785–795

[79] Lopez AR, Cook J, Deininger PL, Derynck R (1992) Dominant negative mutants of transforming growth factor-β1 inhibit the secretion of different transforming growth factor-beta isoforms. Mol Cell Biol 12:1674–1679

[80] Lu J, Isaji T, Im S, Fukuda T, Hashii N, Takakura D, Kawasaki N, Gu J (2014) beta-Galactoside alpha2,6-sialyltranferase 1 promotes transforming growth factor-β-mediated epithelial-mesenchymal transition. J Biol Chem 289:34627–34641

[81] Lu W, Kang Y (2019) Epithelial-mesenchymal plasticity in cancer progression and metastasis. Dev Cell 49:361–374

[82] Luo K (2017) Signaling cross talk between TGF-β/Smad and other signaling pathways. Cold Spring Harb Perspect Biol 9:1–28

[83] Lux A, Gallione CJ, Marchuk DA (2000) Expression analysis of endoglin missense and truncation mutations: insights into protein structure and disease mechanisms. Hum Mol Genet 9:745–755

[84] Lynch TP, Ferrer CM, Jackson SR, Shahriari KS, Vosseller K, Reginato MJ (2012) Critical role of O-linked beta-N-acetylglucosamine transferase in prostate cancer invasion, angiogenesis, and metastasis. J Biol Chem 287:11070–11081

[85] Ma J, Hart GW (2014) O-GlcNAc profiling: from proteins to proteomes. Clin Proteomics 11(8):1–16

[86] Marsico G, Russo L, Quondamatteo F, Pandit A (2018) Glycosylation and integrin regulation in cancer. Trends Cancer 4:537–552

[87] Massague J (2000) How cells read TGF-β signals. Nat Rev Mol Cell Biol 1:169–178

[88] Massague J (2012) TGFβ signalling in context. Nat Rev Mol Cell Biol 13:616–630

[89] Matsumoto K, Yokote H, Arao T, Maegawa M, Tanaka K, Fujita Y, Shimizu C, Hanafusa T, Fujiwara Y, Nishio K (2008) N-Glycan fucosylation of epidermal growth factor receptor modulates receptor activity and sensitivity to epidermal growth factor receptor tyrosine kinase inhibitor. Cancer Sci 99:1611–1617

[90] McMahon GA, Dignam JD, Gentry LE (1996) Structural characterization of the latent complex between transforming growth factor β1 and β1-latency-associated peptide. Biochem J 313(Pt 1):343–351

[91] Melo SA, Luecke LB, Kahlert C, Fernandez AF, Gammon ST, Kaye J, LeBleu VS, Mittendorf EA, Weitz J, Rahbari N (2015) Glypican-1 identifies cancer exosomes and detects early pancreatic cancer. Nature 523:177–182

[92] Mendonsa AM, Na TY, Gumbiner BM (2018) E-cadherin in contact inhibition and cancer. Oncogene 37:4769–4780

[93] Meurer S, Wimmer AE, Leur EV, Weiskirchen R (2019) Endoglin trafficking/exosomal targeting in liver cells depends on N-glycosylation. Cells 8:1–24

[94] Mi W, Gu Y, Han C, Liu H, Fan Q, Zhang X, Cong Q, Yu W (2011) O-GlcNAcylation is a novel regulator of lung and colon cancer malignancy. Biochim Biophys Acta 1812:514–519

[95] Miyazono K, Heldin CH (1989) Role for carbohydrate structures in TGF-β1 latency. Nature 338:158–160

[96] Miyazono K, Thyberg J, Heldin CH (1992) Retention of the transforming growth factor-β1 precursor in the Golgi complex in a latent endoglycosidase H-sensitive form. J Biol Chem 267:5668–5675

[97] Moustakas A, Heldin CH (2016) Mechanisms of TGFβ-induced epithelial-mesenchymal transition. J Clin Med 5:63

[98] Mukherjee P, Faber AC, Shelton LM, Baek RC, Chiles TC, Seyfried TN (2008) Thematic review series: sphingolipids. Ganglioside GM3 suppresses the proangiogenic effects of vascular endothelial growth factor and ganglioside GD1a. J Lipid Res 49:929–938

[99] Nagae M, Kizuka Y, Mihara E, Kitago Y, Hanashima S, Ito Y, Takagi J, Taniguchi N, Yamaguchi Y (2018) Structure and mechanism of cancer-associated N-acetylglucosaminyl-transferase-V. Nat Commun 9(3380):1–12

[100] Nickel J, Ten Dijke P, Mueller TD (2018) TGF-β family co-receptor function and signaling. Acta Biochim Biophys Sin (Shanghai) 50:12–36

[101] O’Brien DP, Sandanayake NS, Jenkinson C, Gentry-Maharaj A, Apostolidou S, Fourkala EO, Camuzeaux S, Blyuss O, Gunu R, Dawnay A (2015) Serum CA19-9 is significantly upregulated up to 2 years before diagnosis with pancreatic cancer: implications for early disease detection. Clin Cancer Res 21:622–631

[102] Partridge EA, Le Roy C, Di Guglielmo GM, Pawling J, Cheung P, Granovsky M, Nabi IR, Wrana JL, Dennis JW (2004) Regulation of cytokine receptors by Golgi N-glycan processing and endocytosis. Science 306:120–124

[103] Pellet-Many C, Frankel P, Jia H, Zachary I (2008) Neuropilins: structure, function and role in disease. Biochem J 411:211–226

[104] Pinho SS, Figueiredo J, Cabral J, Carvalho S, Dourado J, Magalhaes A, Gartner F, Mendonfa AM, Isaji T, Gu J (2013) E-cadherin and adherens-junctions stability in gastric carcinoma: functional implications of glycosyltransferases involving N-glycan branching biosynthesis, N-acetylglucosaminyltransferases III and V. Biochim Biophys Acta 1830:2690–2700

[105] Pinho SS, Reis CA (2015) Glycosylation in cancer: mechanisms and clinical implications. Nat Rev Cancer 15:540–555

[106] Pinho SS, Reis CA, Paredes J, Magalhaes AM, Ferreira AC, Figueiredo J, Xiaogang W, Carneiro F, Gartner F, Seruca R (2009) The role of N-acetylglucosaminyltransferase III and V in the post-transcriptional modifications of E-cadherin. Hum Mol Genet 18:2599–2608

[107] Priglinger CS, Obermann J, Szober CM, Merl-Pham J, Ohmayer U, Behler J, Gruhn F, Kreutzer TC, Wertheimer C, Geerlof A (2016) Epithelial-to-mesenchymal transition of RPE cells in vitro confers increased beta1,6-N-glycosylation and increased susceptibility to galectin-3 binding. PLoS ONE 11(e0146887):1–25

[108] Purchio AF, Cooper JA, Brunner AM, Lioubin MN, Gentry LE, Kovacina KS, Roth RA, Marquardt H (1988) Identification of mannose 6-phosphate in two asparagine-linked sugar chains of recombinant transforming growth factor-β1 precursor. J Biol Chem 263:14211–14215

[109] Regina Todeschini A, Hakomori SI (2008) Functional role of glycosphingolipids and gangliosides in control of cell adhesion, motility, and growth, through glycosynaptic microdomains. Biochim Biophys Acta 1780:421–433

[110] Reily C, Stewart TJ, Renfrow MB, Novak J (2019) Glycosylation in health and disease. Nat Rev Nephrol 15:346–366

[111] Robertson IB, Horiguchi M, Zilberberg L, Dabovic B, Hadjiolova K, Rifkin DB (2015) Latent TGF-β-binding proteins. Matrix Biol 47:44–53

[112] Robertson IB, Rifkin DB (2016) Regulation of the Bioavailability of TGF-β and TGF-β-Related Proteins. Cold Spring Harb Perspect Biol 8:1–25

[113] Rodrigues JG, Balmana M, Macedo JA, Pocas J, Fernandes A, de-Freitas-Junior JCM, Pinho SS, Gomes J, Magalhaes A, Gomes C (2018) Glycosylation in cancer: selected roles in tumour progression, immune modulation and metastasis. Cell Immunol 333:46–57

[114] Sarkar TR, Battula VL, Werden SJ, Vijay GV, Ramirez-Pena EQ, Taube JH, Chang JT, Miura N, Porter W, Sphyris N (2015) GD3 synthase regulates epithelial-mesenchymal transition and metastasis in breast cancer. Oncogene 34:2958–2967

[115] Schnaar RL, Kinoshita T (2015) Glycosphingolipids. In: Varki A, Cummings RD, Esko JD, Stanley P, Hart GW, Aebi M, Darvill AG, Kinoshita T, Packer NH et al (eds) Essentials of glycobiology, 3rd edn. Cold Spring Harbor, New York, pp 125–135

[116] Sha X, Brunner AM, Purchio AF, Gentry LE (1989) Transforming growth factor β1: importance of glycosylation and acidic proteases for processing and secretion. Mol Endocrinol 3:1090–1098

[117] Takeuchi H, Haltiwanger RS (2014) Significance of glycosylation in Notch signaling. Biochem Biophys Res Commun 453:235–242

[118] Taniguchi N, Kizuka Y (2015) Glycans and cancer: role of N-glycans in cancer biomarker, progression and metastasis, and therapeutics. Adv Cancer Res 126:11–51

[119] ten Dijke P, Goumans MJ, Pardali E (2008) Endoglin in angiogenesis and vascular diseases. Angiogenesis 11:79–89

[120] Tu CF, Wu MY, Lin YC, Kannagi R, Yang RB (2017) FUT8 promotes breast cancer cell invasiveness by remodeling TGF-β receptor core fucosylation. Breast Cancer Res 19(111):1–16

[121] van Kooyk Y, Kalay H, Garcia-Vallejo JJ (2013) Analytical tools for the study of cellular glycosylation in the immune system. Front Immunol 4(451):1–6

[122] Venkatachalam MA, Weinberg JM (2013) New wrinkles in old receptors: core fucosylation is yet another target to inhibit TGF-β signaling. Kidney Int 84:11–14

[123] Ventura E, Weller M, Macnair W, Eschbach K, Beisel C, Cordazzo C, Claassen M, Zardi L, Burghardt I (2018) TGF-β induces oncofetal fibronectin that, in turn, modulates TGF-β superfamily signaling in endothelial cells. J Cell Sci 131:209619

[124] Wang M, Zhu J, Lubman DM, Gao C (2019) Aberrant glycosylation and cancer biomarker discovery: a promising and thorny journey. Clin Chem Lab Med 57:407–416

[125] Wang X, Inoue S, Gu J, Miyoshi E, Noda K, Li W, Mizuno-Horikawa Y, Nakano M, Asahi M, Takahashi M (2005) Dysregulation of TGF-β1 receptor activation leads to abnormal lung development and emphysema-like phenotype in core fucose-deficient mice. Proc Natl Acad Sci USA 102:15791–15796

[126] Wu MH, Chen YL, Lee KH, Chang CC, Cheng TM, Wu SY, Tu CC, Tsui WL (2017) Glycosylation-dependent galectin-1/neuropilin-1 interactions promote liver fibrosis through activation of TGF-β-and PDGF-like signals in hepatic stellate cells. Sci Rep 7(11006):1–16

[127] Xu P, Liu J, Derynck R (2012a) Post-translational regulation of TGF-β receptor and Smad signaling. FEBS Lett 586:1871–1884

[128] Xu Q, Isaji T, Lu Y, Gu W, Kondo M, Fukuda T, Du Y, Gu J (2012b) Roles of N-acetylglucosaminyltransferase III in epithelial-to-mesenchymal transition induced by transforming growth factor beta1 (TGF-β1) in epithelial cell lines. J Biol Chem 287:16563–16574

[129] Xu Y, Uddin N, Wagner GK (2018) Covalent probes for carbohydrate-active enzymes: from glycosidases to glycosyltransferases. Methods Enzymol 598:237–265

[130] Yang J, Antin P, Berx G, Blanpain C, Brabletz T, Bronner M, Campbell K, Cano A, Casanova J, Christofori G (2020) Guidelines and definitions for research on epithelial-mesenchymal transition. Nat Rev Mol Cell Biol 7:131

[131] Yang Y, Dignam JD, Gentry LE (1997) Role of carbohydrate structures in the binding of β1-latency-associated peptide to ligands. Biochemistry 36:11923–11932

[132] Yu L, Hebert MC, Zhang YE (2002) TGF-β receptor-activated p38 MAP kinase mediates Smad-independent TGF-β responses. EMBO J 21:3749–3759

[133] Zhang H, Meng F, Wu S, Kreike B, Sethi S, Chen W, Miller FR, Wu G (2011) Engagement of I-branching {beta}-1,6-N-acetylglucosaminyltransferase 2 in breast cancer metastasis and TGF-β signaling. Cancer Res 71:4846–4856

[134] Zhang L, Luo S, Zhang B (2016) The use of lectin microarray for assessing glycosylation of therapeutic proteins. MAbs 8:524–535

[135] Zhang YE (2017) Non-Smad signaling pathways of the TGF-β family. Cold Spring Harb Perspect Biol 9:1–18

[136] Zhao Y, Itoh S, Wang X, Isaji T, Miyoshi E, Kariya Y, Miyazaki K, Kawasaki N, Taniguchi N, Gu J (2006) Deletion of core fucosylation on α3β1 integrin down-regulates its functions. J Biol Chem 281:38343–38350

[137] Zhao Y, Sato Y, Isaji T, Fukuda T, Matsumoto A, Miyoshi E, Gu J, Taniguchi N (2008) Branched N-glycans regulate the biological functions of integrins and cadherins. FEBS J 275:1939–1948

RIGHTS & PERMISSIONS

2020 The Author(s) 2020